We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App





Cheap 5-Minute COVID-19 Test Accurately Detects SARS-CoV-2 Antibody in Blood or Saliva

By LabMedica International staff writers
Posted on 17 Sep 2021
Researchers have developed an ultrafast, low-cost, label-free, and portable SARS-CoV-2 immunoglobulin G (IgG) detection platform based on organic electrochemical transistors (OECTs), which can be remotely controlled by a mobile phone.

The device developed by researchers at The Hong Kong Polytechnic University (Hong Kong) can detect SARS-CoV-2 IgG with an ultralow detection limit of 1 fM in aqueous solutions and 10 fM in serum and saliva within five minutes.

Currently, COVID-19 antibodies are detected mainly by enzyme-linked immunosorbent assay (ELISA) and colloidal gold lateral flow immunoassays (LFIAs). More...
ELISA is highly accurate, but the technical procedure is complicated, making it difficult to achieve both portable and high-throughput detection. LFIA is easy to operate and portable, but with relatively low sensitivity and prone to misdiagnosis. Therefore, for the detection of COVID-19 antibody, there is a need to develop a highly sensitive and rapid detection method that can be easily operated for point-of-care testing and screening of large populations. In addition to serum-based assays, SARS-CoV-2 IgG can be detected in saliva, with the advantages of a noninvasive process and the possibility of self-collection of samples. Because antibody concentration in human saliva is several orders of magnitude lower than in serum, high analytical sensitivity is needed

Organic electrochemical transistors (OECTs) have been recognized as high-performance transducers and amplifiers that can convert biological signals into electrical signals. OECT-based biosensors have the advantages of high sensitivity, low cost, easy fabrication, and mechanical flexibility and are suitable for high-throughput and multiplexing detections of biomarkers. In recent years, OECTs have been successfully used in the detection of various biomolecules, including nucleic acids, proteins, and metabolite.

In the latest study, the researchers used OECT-based biosensors for the detection of SARS-CoV-2 IgG that is controlled by a portable meter and a mobile phone through Bluetooth. The team developed portable, label-free, and low-cost biosensors based on OECTs for rapid and highly sensitive detections of SARS-CoV-2 IgG. The gate electrodes of the OECTs were modified with SARS-CoV-2 spike proteins that can selectively capture the IgG through the specific antibody-antigen reaction. The positively charged IgG molecules in aqueous solutions form electrical dipoles on gate surfaces and modulate the channel currents of the OECTs. By optimizing the measurement conditions, including electrolyte ion concentration and pH value, high device sensitivity was achieved. The detection limits of the devices can reach 1 fM in aqueous solutions and 10 fM in saliva and serum samples, which are much better than many existing electrochemical methods. Notably, the detectable region can cover the concentrations of the specific antibody in the serum and saliva of patients with COVID-19, promising a high potential for practical applications. Faster detection of IgG has been realized by applying voltage pulses on the gates of OECTs during incubation, and stable signal can be obtained within five minutes. The testing process can be remotely operated with a mobile phone by controlling a portable meter via Bluetooth, which can meet the requirement of fast and point-of-care detections of COVID-19 antibody. In addition to COVID-19 antibody, the biosensor can also be used in the fast detections of many other diseases that may generate antibodies.

Related Links:
The Hong Kong Polytechnic University


Gold Member
Universal Transport Solution
Puritan®UniTranz-RT
Online QC Software
Acusera 24•7
Japanese Encephalitis Test
Japanese Encephalitis Virus Real Time PCR Kit
Automatic CLIA Analyzer
Shine i6000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Graphical Abstract (Morgane Fournier et al., Cell (2026). DOI: 10.1016/j.cell.2026.04.013)

Study Reveals Immune Mechanism Driving Severe COVID-19 Progression

Severe COVID-19 has highlighted gaps in understanding of early antiviral responses, particularly why some patients deteriorate despite timely care. Type I interferons are central to host defense, yet their... Read more

Pathology

view channel
Image: Agilent’s PD-L1 IHC 22C3 pharmDx has received EU certification as a companion diagnostic to identify PD-L1–positive ovarian, fallopian tube, or primary peritoneal carcinoma patients eligible for KEYTRUDA (Photo courtesy of Agilent)

PD-L1 Assay Guides Pembrolizumab Eligibility in Ovarian, Fallopian Tube, and Peritoneal Cancers

Agilent Technologies’ PD-L1 IHC 22C3 pharmDx (Code SK006) has received European Union certification as a companion diagnostic to aid in identifying patients with epithelial ovarian, fallopian tube, or... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.